The consortium reported significant associations of breast cancer risk with total testosterone, SHBG, IGF-1 and total and calculated free oestradiol in pre-menopausal women and with total testosterone, SHBG and IGF-1, as well as with total and calculated free oestradiol, in post-menopausal women. The gene discussed is IGF1; the disease is breast carcinoma.